Injectable, biodegradable bone cements and methods of making and using same

US10342893B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10342893-B2
Application numberUS-201314375927-A
CountryUS
Kind codeB2
Filing dateJan 31, 2013
Priority dateJan 31, 2012
Publication dateJul 9, 2019
Grant dateJul 9, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.

First claim

Opening claim text (preview).

What is claimed is: 1. A bone cement composition comprising: a magnesium phosphate comprising newberyite; a biocompatible polymer; and silica sol; wherein the bone cement composition is in the form of an injectable paste or a putty. 2. The bone cement of claim 1 , wherein the biocompatible polymer comprises chitosan. 3. The bone cement of claim 1 , wherein the biocompatible polymer is surface-phosphorylated. 4. A bone cement composition comprising: a magnesium phosphate comprising newberyite; and silica sol; wherein the bone cement composition is in the form of an injectable paste or a putty. 5. The bone cement composition of claim 4 , further comprising an additive selected from the group consisting of: proteins, osteoinductive materials, osteoconductive materials, X-ray opacifying agents, medicaments, supporting or strengthening filler materials, crystal growth adjusters, viscosity modifiers, pore-forming agents, antibiotics, antiseptics, growth factors, chemotherapeutic agents, bone resorption inhibitors, color change agents, immersing liquids, carboxylates, carboxylic acids, α-hydroxyl acids, collagen, pyrophosphates, sulfates, and metallic ions. 6. The bone cement composition of claim 4 , further comprising a nonaqueous extender comprising glycerine and/or propylene glycol, wherein the bone cement composition is in the form of a putty. 7. A bone cement composition comprising: a magnesium phosphate comprising newberyite; and silica; wherein the bone cement composition is in the form of a hardened mass.

Assignees

Inventors

Classifications

  • Phosphate cements (apatite A61K6/838) · CPC title

  • Polysaccharides · CPC title

  • comprising phosphorus-containing compounds · CPC title

  • Phosphorus-containing materials, e.g. apatite · CPC title

  • Coatings containing a composite material such as inorganic/organic, i.e. material comprising different phases · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10342893B2 cover?
Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form …
Who is the assignee on this patent?
Univ Toledo
What technology area does this patent fall under?
Primary CPC classification A61L24/0015. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).